Pathogenic bacteria significantly
contribute to elevated morbidity
and mortality rates, highlighting the urgent need for early and precise
detection. Currently, there is a paucity of effective broad-spectrum
methods for detecting pathogenic bacteria. We have developed an innovative
proton-responsive series piezoelectric quartz crystal (PR-SPQC) platform
for the broad-spectrum identification of pathogenic bacteria. This
was achieved by retrieving and aligning sequences from the NCBI GenBank
database to identify and validate 16S rRNA oligonucleotide sequences
that are signatures of pathogenic bacteria but absent in humans or
fungi. The hyperbranched rolling circle amplification, activated exclusively
by the screened target, exponentially generates protons that are detected
by SPQC through a 2D polyaniline (PANI) film. The PR-SPQC platform
demonstrates broad-spectrum capabilities in detecting pathogenic bacteria,
with a detection limit of 2 CFU/mL within 90 min. Clinical testing
of blood samples yielded satisfactory results. With its advantages
in miniaturization, cost efficiency, and suitability for point-of-care
testing, PR-SPQC has the potential to be extensively used for the
rapid identification of diverse pathogenic bacteria within clinical
practice and public health sectors.